Page results
-
The tissue viability team is committed to providing support, training and education to clinical staff, patients and carers about maintaining, promoting skin integrity and preventing pressure sores.
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
-
Our vascular service has a major emphasis on endovascular (minimally invasive) treatments for vascular diseases, and this approach has largely replaced conventional open vascular surgery at UCLH.
-
Professor Pandya is a consultant in fetal medicine at UCLH
-
The department offers a wide range of investigations and treatment for benign and cancerous surgical diseases, with specialisation in lower and upper GI surgery (including for weight loss).
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
This page provides information for employers, teachers, special needs education coordinators (SENCo) and other professionals who work alongside someone with Galactosaemia.
-
Our pain clinics are patient-centred and evidence-based, encouraging patients to self-manage their persistent facial pain.
-
The specialist allergy and clinical immunology service deals with the diagnosis and management of allergies and related immune system disorders in adults.
-
The snoring and sleep disorders clinic offers, out-patient consultation including flexible endoscopy to assess upper airway collapse. Multidisciplinary team involvement for planning treatment.
File results
-
FOI/2022/0147 - Oesophageal and gastric cancer drug treatments
-
FOI/2022/0148 - Maternity related overseas services
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0151 - Omnipod patch pump
-
FOI/2022/0153 - Central water treatment equipment for renal dialysis
-
FOI/2022/0154 - Immunoglobulin treatments (for any disease)
-
FOI/2022/0155 - Patient hospital bedside and electronic patient notes
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0167 - Prostate cancer drug treatments
-
FOI/2022/0168 - Geographic locations of patients